Safety and Pharmacokinetic Study of Y242 in Adult Subjects

NCT01515319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Y242
DRUG: 0.9% saline

Sponsor

Imperial College London

Collaborators

[object Object]